company background image
IQV logo

IQVIA Holdings NYSE:IQV Lagerbericht

Letzter Preis

US$215.51

Marktkapitalisierung

US$39.3b

7D

-0.8%

1Y

0.2%

Aktualisiert

11 Jun, 2024

Daten

Finanzdaten des Unternehmens +

IQVIA Holdings Inc.

NYSE:IQV Lagerbericht

Marktkapitalisierung: US$39.3b

Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

IQV Aktienübersicht

IQVIA Holdings Inc. bietet fortschrittliche Analysen, Technologielösungen und klinische Forschungsdienstleistungen für die Life-Science-Industrie in Nord- und Südamerika, Europa, Afrika und im asiatisch-pazifischen Raum an.

Über das Unternehmen

IQV fundamental analysis
Snowflake Score
Valuation5/6
Future Growth2/6
Past Performance4/6
Financial Health1/6
Dividends0/6

Belohnungen

29.7% unter unserer Schätzung des beizulegenden Zeitwerts gehandelt
Prognostiziertes Gewinnwachstum 12.93% pro Jahr
Die Erträge stiegen im vergangenen Jahr um 28.6%
Analysten sind sich einig, dass der Aktienkurs um 20.6%

Risikoanalyse

Die Verschuldung ist durch den operativer Cashflow nicht gut gedeckt

IQVIA Holdings Inc. Wettbewerber

Agilent Technologies

NYSE:A

US$38.8b

Mettler-Toledo International

NYSE:MTD

US$30.8b

West Pharmaceutical Services

NYSE:WST

US$23.3b

Waters

NYSE:WAT

US$17.9b

Preisentwicklung & Leistung

Summary of all time highs, changes and price drops for IQVIA Holdings
Historical stock prices
Current Share PriceUS$215.51
52 Week HighUS$261.73
52 Week LowUS$167.42
Beta1.54
1 Month Change-7.93%
3 Month Change-15.70%
1 Year Change0.18%
3 Year Change-12.67%
5 Year Change47.95%
Change since IPO411.78%

Aktuelle Nachrichten und Updates

An Intrinsic Calculation For IQVIA Holdings Inc. (NYSE:IQV) Suggests It's 33% Undervalued

Jun 04
An Intrinsic Calculation For IQVIA Holdings Inc. (NYSE:IQV) Suggests It's 33% Undervalued

IQVIA: Long-Term Compounder Throwing Off Free Cash Flow

May 27

Is It Time To Consider Buying IQVIA Holdings Inc. (NYSE:IQV)?

Apr 24
Is It Time To Consider Buying IQVIA Holdings Inc. (NYSE:IQV)?

Recent updates

An Intrinsic Calculation For IQVIA Holdings Inc. (NYSE:IQV) Suggests It's 33% Undervalued

Jun 04
An Intrinsic Calculation For IQVIA Holdings Inc. (NYSE:IQV) Suggests It's 33% Undervalued

IQVIA: Long-Term Compounder Throwing Off Free Cash Flow

May 27

Is It Time To Consider Buying IQVIA Holdings Inc. (NYSE:IQV)?

Apr 24
Is It Time To Consider Buying IQVIA Holdings Inc. (NYSE:IQV)?

Is IQVIA Holdings (NYSE:IQV) Using Too Much Debt?

Apr 11
Is IQVIA Holdings (NYSE:IQV) Using Too Much Debt?

IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Not Quite Adding Up

Mar 27
IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Not Quite Adding Up

Here's Why IQVIA Holdings (NYSE:IQV) Has Caught The Eye Of Investors

Mar 14
Here's Why IQVIA Holdings (NYSE:IQV) Has Caught The Eye Of Investors

IQVIA Holdings: Strong Q4 Results Suggest A Bullish 2024

Feb 22

Is IQVIA Holdings Inc. (NYSE:IQV) Trading At A 29% Discount?

Jan 23
Is IQVIA Holdings Inc. (NYSE:IQV) Trading At A 29% Discount?

Market Participants Recognise IQVIA Holdings Inc.'s (NYSE:IQV) Earnings

Dec 24
Market Participants Recognise IQVIA Holdings Inc.'s (NYSE:IQV) Earnings

We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

Dec 08
We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

Should You Investigate IQVIA Holdings Inc. (NYSE:IQV) At US$205?

Nov 23
Should You Investigate IQVIA Holdings Inc. (NYSE:IQV) At US$205?

IQVIA Q3: TAS Segment Remains The Problem Child

Nov 21

IQVIA: I Would Stay Away Until Debt Issues Are Resolved

Nov 12

Is There An Opportunity With IQVIA Holdings Inc.'s (NYSE:IQV) 32% Undervaluation?

Oct 08
Is There An Opportunity With IQVIA Holdings Inc.'s (NYSE:IQV) 32% Undervaluation?

IQVIA: Stock To Remain Rangebound As I Expect Weak Numbers In The Near Term

Sep 07

Is IQVIA Holdings (NYSE:IQV) A Risky Investment?

Sep 04
Is IQVIA Holdings (NYSE:IQV) A Risky Investment?

Why IQVIA Holdings Inc. (NYSE:IQV) Could Be Worth Watching

Aug 11
Why IQVIA Holdings Inc. (NYSE:IQV) Could Be Worth Watching

IQVIA Holdings Q2: Breaking Ground And Beating Expectations

Aug 03

IQVIA Holdings Inc.'s (NYSE:IQV) Intrinsic Value Is Potentially 43% Above Its Share Price

Jun 27
IQVIA Holdings Inc.'s (NYSE:IQV) Intrinsic Value Is Potentially 43% Above Its Share Price

IQVIA Holdings (NYSE:IQV) Has A Pretty Healthy Balance Sheet

Jun 05
IQVIA Holdings (NYSE:IQV) Has A Pretty Healthy Balance Sheet

IQVIA Holdings: A Possible Beat And Raise Scenario In The Works

May 23

What Does IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Indicate?

May 04
What Does IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Indicate?

A Look At The Fair Value Of IQVIA Holdings Inc. (NYSE:IQV)

Mar 19
A Look At The Fair Value Of IQVIA Holdings Inc. (NYSE:IQV)

Does IQVIA Holdings (NYSE:IQV) Have A Healthy Balance Sheet?

Mar 05
Does IQVIA Holdings (NYSE:IQV) Have A Healthy Balance Sheet?

Here's Why We Think IQVIA Holdings (NYSE:IQV) Might Deserve Your Attention Today

Feb 12
Here's Why We Think IQVIA Holdings (NYSE:IQV) Might Deserve Your Attention Today

IQVIA Q4 2022 Earnings Preview

Feb 09

When Should You Buy IQVIA Holdings Inc. (NYSE:IQV)?

Jan 29
When Should You Buy IQVIA Holdings Inc. (NYSE:IQV)?

IQVIA Holdings: Premium Valuation Is Justified For An Industry Leader

Jan 24

We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

Nov 09
We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

IQVIA Holdings Sees Digital Opportunities, But Debt Drags Growth

Nov 02

IQVIA Q3 2022 Earnings Preview

Oct 25

Is Now The Time To Look At Buying IQVIA Holdings Inc. (NYSE:IQV)?

Oct 02
Is Now The Time To Look At Buying IQVIA Holdings Inc. (NYSE:IQV)?

IQVIA: Rebound Is Likely But Downtrend Is Still Intact (Technical Analysis)

Sep 19

With EPS Growth And More, IQVIA Holdings (NYSE:IQV) Makes An Interesting Case

Aug 22
With EPS Growth And More, IQVIA Holdings (NYSE:IQV) Makes An Interesting Case

GSK, Iqvia launch Vaccine Track platform to highlight vaccine trends publicly in US

Aug 11

We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

Aug 08
We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

IQVIA: Resiliency And Quality Never Left, Q2 Earnings Evidence The Same

Jul 28

Are Investors Undervaluing IQVIA Holdings Inc. (NYSE:IQV) By 48%?

Jul 26
Are Investors Undervaluing IQVIA Holdings Inc. (NYSE:IQV) By 48%?

IQVIA Non-GAAP EPS of $2.44 beats by $0.06, revenue of $3.54B beats by $50M, raises FY22 guidance

Jul 21

IQVIA A Smart Choice In A High-Inflation Environment

Apr 29

When Should You Buy IQVIA Holdings Inc. (NYSE:IQV)?

Mar 28
When Should You Buy IQVIA Holdings Inc. (NYSE:IQV)?

Here's Why We Think IQVIA Holdings (NYSE:IQV) Is Well Worth Watching

Mar 01
Here's Why We Think IQVIA Holdings (NYSE:IQV) Is Well Worth Watching

IQVIA: Intelligent Healthcare Solutions For A Growing Market

Feb 19

IQVIA Holdings (NYSE:IQV) Seems To Use Debt Quite Sensibly

Feb 17
IQVIA Holdings (NYSE:IQV) Seems To Use Debt Quite Sensibly

Aktionärsrenditen

IQVUS Life SciencesUS Markt
7D-0.8%0.2%1.3%
1Y0.2%1.8%21.0%

Rendite im Vergleich zur Industrie: IQV unter dem Niveau der Branche US Life Sciences, die im vergangenen Jahr eine Rendite von 5.4% erzielte.

Rendite vs. Markt: IQV hinter dem Markt US zurück, der im vergangenen Jahr eine Rendite von 25.6 erzielte.

Preisvolatilität

Is IQV's price volatile compared to industry and market?
IQV volatility
IQV Average Weekly Movement2.9%
Life Sciences Industry Average Movement6.8%
Market Average Movement5.8%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market2.8%

Stabiler Aktienkurs: IQV hatte in den letzten 3 Monaten keine nennenswerte Preisvolatilität.

Volatilität im Zeitverlauf: IQVDie wöchentliche Volatilität (3%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

GegründetMitarbeiterCEOWebsite
n/a87,000Ari Bousbibwww.iqvia.com

IQVIA Holdings Inc. bietet fortschrittliche Analysen, Technologielösungen und klinische Forschungsdienstleistungen für die Life-Science-Industrie in Nord- und Südamerika, Europa, Afrika und im asiatisch-pazifischen Raum an. Das Unternehmen ist in drei Segmenten tätig: Technology & Analytics Solutions, Research & Development Solutions und Contract Sales & Medical Solutions. Das Segment Technology & Analytics Solutions bietet eine Reihe von Cloud-basierten Anwendungen und die dazugehörigen Implementierungsdienste, praxisnahe Lösungen, die es den Kunden aus dem Bereich Biowissenschaften und Anbietern ermöglichen, Erkenntnisse zu gewinnen und zu verbreiten, die die Entscheidungsfindung im Gesundheitswesen unterstützen und die Ergebnisse für die Patienten verbessern, sowie strategische und Implementierungsberatungsdienste, wie z. B. fortschrittliche Analyse- und Geschäftsprozess-Outsourcingdienste.

IQVIA Holdings Inc.'s Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von IQVIA Holdings im Vergleich zum Marktanteil des Unternehmens?
IQV grundlegende Statistiken
MarktanteilUS$39.32b
Gewinn(TTM)US$1.36b
Umsatz(TTM)US$15.07b

28.9x

Kurs-Gewinn-Verhältnis

2.6x

Kurs-Umsatz-Verhältnis

Ist IQV zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
IQV Gewinn- und Verlustrechnung (TTM)
EinnahmenUS$15.07b
Kosten der EinnahmenUS$9.79b
BruttogewinnUS$5.28b
Sonstige AusgabenUS$3.92b
UmsatzUS$1.36b

Zuletzt gemeldete Gewinne

Mar 31, 2024

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)7.45
Bruttomarge35.03%
Nettogewinnspanne9.01%
Schulden/Eigenkapital-Verhältnis213.6%

Wie hat sich IQV auf lange Sicht entwickelt?

Historische Performance und Vergleiche